Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.
作者信息
Broome J D
出版信息
Br J Cancer. 1968 Sep;22(3):595-602. doi: 10.1038/bjc.1968.71.
Abstract
摘要
相似文献
1
Factors which may influence the effectiveness of L-asparaginases as tumor inhibitors.可能影响L-天冬酰胺酶作为肿瘤抑制剂有效性的因素。
Br J Cancer. 1968 Sep;22(3):595-602. doi: 10.1038/bjc.1968.71.
2
L-asparaginase: a review.L-天冬酰胺酶综述
Adv Enzymol Relat Areas Mol Biol. 1973;39:185-248. doi: 10.1002/9780470122846.ch3.
3
[The antitumor activity of L-asparaginase].[L-天冬酰胺酶的抗肿瘤活性]
Acta Vitaminol Enzymol. 1969;23(3):111-24.
4
Gel entrapped L-asparaginase: kinetic behavior and antitumor activity.凝胶包封的L-天冬酰胺酶：动力学行为和抗肿瘤活性。
J Pharmacol Exp Ther. 1975 Nov;195(2):382-8.
5
6
[L-asparaginase--first specific cytostatic].[L-天冬酰胺酶——首个特异性细胞生长抑制剂]
Arzneimittelforschung. 1968 Nov;18(11):1380-6.
7
8
Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells.L-天冬酰胺酶抑制肿瘤机制的研究。该酶对小鼠血液、正常组织及6C3HED淋巴瘤中天冬酰胺水平的影响：天冬酰胺酶敏感及耐药淋巴瘤细胞中天冬酰胺生成与利用的差异。
J Exp Med. 1968 Jun 1;127(6):1055-72. doi: 10.1084/jem.127.6.1055.
9
Acrylic microspheres in vivo VI: antitumor effect of microparticles with immobilized L-asparaginase against 6C3HED lymphoma.体内丙烯酸微球VI：固定化L-天冬酰胺酶微粒对6C3HED淋巴瘤的抗肿瘤作用
J Pharm Sci. 1983 Jun;72(6):654-8. doi: 10.1002/jps.2600720616.
10
Asparagine synthetase in normal and malignant tissues: correlation with tumor sensitivity to asparaginase.正常组织和恶性组织中的天冬酰胺合成酶：与肿瘤对天冬酰胺酶敏感性的相关性。
Arch Biochem Biophys. 1968 Sep 20;127(1):645-54. doi: 10.1016/0003-9861(68)90273-7.
引用本文的文献
1
Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.L-天冬酰胺酶作为急性淋巴细胞白血病治疗药物的结构、副作用及活性测定概述
RSC Med Chem. 2022 Jan 12;13(2):117-128. doi: 10.1039/d1md00344e. eCollection 2022 Feb 23.
2
Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia.复发急性淋巴细胞白血病患者肌内注射培门冬酶的随机、平行组、开放标签生物等效性试验
JCO Glob Oncol. 2020 Jul;6:1009-1016. doi: 10.1200/GO.20.00113.
3
Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity.酿酒酵母源重组 L-天冬酰胺酶 1：一种具有抗肿瘤活性的别构酶。
Sci Rep. 2016 Nov 8;6:36239. doi: 10.1038/srep36239.
4
Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.沙门氏菌天冬酰胺酶介导的天冬酰胺剥夺会抑制活化诱导的T细胞代谢重编程。
J Leukoc Biol. 2016 Feb;99(2):387-98. doi: 10.1189/jlb.4A0615-252R. Epub 2015 Oct 23.
5
Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme.菊欧文氏菌L-天冬酰胺酶的重组脱酰胺突变体与野生型酶相比具有相似或更高的活性。
Mol Biotechnol. 2014 Oct;56(10):865-77. doi: 10.1007/s12033-014-9766-9.
6
Measurement of subvisible particulates in lyophilised Erwinia chrysanthemi L-asparaginase and relationship with clinical experience.测定冷冻干燥的欧文氏菌属 L-天冬酰胺酶中的亚可见颗粒与临床经验的关系。
AAPS J. 2014 Jul;16(4):784-90. doi: 10.1208/s12248-014-9612-9. Epub 2014 May 23.
7
The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.抗天冬酰胺酶抗体对不同L-天冬酰胺酶制剂的交叉反应性。
Clin Exp Med. 2009 Jun;9(2):113-6. doi: 10.1007/s10238-008-0026-9. Epub 2009 Jan 30.
8
Production and properties of asparaginase from a new Erwinia sp.一种新型欧文氏菌属细菌产天冬酰胺酶的制备及其性质
Folia Microbiol (Praha). 2002;47(5):473-6. doi: 10.1007/BF02818783.
9
Isolation and characterization of a Chlamydomonas L-asparaginase.莱茵衣藻L-天冬酰胺酶的分离与鉴定
Biochem J. 1982 Apr 1;203(1):109-15. doi: 10.1042/bj2030109.
10
[Blood level course in humans following administration of 2 various kinds of L-asparaginase].[两种不同类型的L-天冬酰胺酶给药后人体血液水平变化过程]
Klin Wochenschr. 1969 Dec 15;47(24):1324-6. doi: 10.1007/BF01484296.
本文引用的文献
1
Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms.与 26 种实验性鼠类肿瘤相关的可传播因子。
Science. 1960 Aug 26;132(3426):545-7. doi: 10.1126/science.132.3426.545.
2
LACTIC DEHYDROGENASE VIRUS.乳酸脱氢酶病毒
Bacteriol Rev. 1965 Jun;29(2):143-60. doi: 10.1128/br.29.2.143-160.1965.
3
MECHANISM OF LACTATE DEHYDROGENASE (LDH) ELEVATION IN VIRUS-INFECTED HOSTS.病毒感染宿主中乳酸脱氢酶（LDH）升高的机制
Life Sci (1962). 1965 Feb;4:487-507. doi: 10.1016/0024-3205(65)90098-6.
4
Lactic dehydrogenase activity in blood.血液中的乳酸脱氢酶活性。
Proc Soc Exp Biol Med. 1955 Oct;90(1):210-3. doi: 10.3181/00379727-90-21985.
5
Two L-asparaginases from E. coli and their action against tumors.来自大肠杆菌的两种L-天冬酰胺酶及其抗肿瘤作用。
Proc Natl Acad Sci U S A. 1966 Nov;56(5):1516-9. doi: 10.1073/pnas.56.5.1516.
6
A comparison of concurrent and delayed tests for antitumor activity of L-asparaginase.L-天冬酰胺酶抗肿瘤活性的同步试验与延迟试验比较。
Proc Soc Exp Biol Med. 1967 Feb;124(2):568-71. doi: 10.3181/00379727-124-31793.
Zotero 插件